INNOVIVA, INC. Debt Securities, Available-for-sale, Current
INNOVIVA, INC. (INVA) had Debt Securities, Available-for-sale, Current of $0 as of 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2021-02-25
- 2020-12-31: Debt Securities, Available-for-sale, Current $0.00.
- 2020-09-30: Debt Securities, Available-for-sale, Current $0.00.
- 2020-06-30: Debt Securities, Available-for-sale, Current $4.00M.
- 2020-03-31: Debt Securities, Available-for-sale, Current $31.97M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-25 |
| 2020-09-30 | $0.00 10-Q · filed 2020-10-28 |
| 2020-06-30 | $4.00M 10-Q · filed 2020-07-29 |
| 2020-03-31 | $31.97M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $72.75M 10-K · filed 2021-02-25 |
| 2019-09-30 | $124.25M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $107.71M 10-Q · filed 2019-07-24 |
| 2019-03-31 | $127.03M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $52.49M 10-K · filed 2020-02-19 |
| 2018-09-30 | $6.87M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $20.32M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $29.32M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $55.74M 10-K · filed 2019-02-19 |
| 2017-09-30 | $29.77M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $7.99M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $10.00M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $32.42M 10-K · filed 2018-02-23 |
| 2016-09-30 | $55.77M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $40.92M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $16.41M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $28.10M 10-K · filed 2017-02-28 |
| 2015-09-30 | $127.45M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $79.68M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $109.95M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $143.70M 10-K · filed 2016-02-24 |
| 2014-09-30 | $143.54M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $126.42M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $245.65M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $321.62M 10-K · filed 2015-02-27 |
| 2013-09-30 | $334.26M 10-Q · filed 2013-11-01 |
| 2013-06-30 | $243.77M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $192.99M 10-Q · filed 2013-05-01 |
| 2012-12-31 | $153.64M 10-K · filed 2014-03-03 |
| 2012-09-30 | $161.21M 10-Q · filed 2012-10-31 |
| 2012-06-30 | $134.39M 10-Q · filed 2012-08-01 |
| 2011-12-31 | $196.14M 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |